Steve Strazza joined legendary investigative journalist Herb Greenberg today to talk about one of the wildest speculative growth stories of the cycle — Hims & Hers ($HIMS).
Herb's been warning about this company since May 2024. And even with the stock doubling since he first flagged it, the red flags are still flying — maybe louder than ever.
Meanwhile, Steve Strazza has been bullish the stock during it's epic rise and trading in and out of options.
This week, $HIMS just had its worst day in history after Novo Nordisk pulled the plug on its partnership.
In this new conversation, Herb pulls back the curtain on the real risk behind Hims, the regulatory landmines it's walking over, and why even the best charts don't always tell the full story.
Now a HIMS bear and a (sometimes) bull get together to get to the bottom of it.
Click here to watch the full conversation.
Herb Greenberg shares deep-dive red flag research and insights from decades of market experience, you'll want to hear what he has to say.
